Hostname: page-component-586b7cd67f-g8jcs Total loading time: 0 Render date: 2024-11-23T07:11:19.444Z Has data issue: false hasContentIssue false
  • English
  • Français

A Case of Amiodarone-Associated Myoclonus Responsive to Levetiracetam

Published online by Cambridge University Press:  02 December 2014

Andres F. Deik  and
Vicki L. Shanker
Andres F. Deik
Affiliation:
Beth Israel Medical Center, New York, NY, USA Email: [email protected]
Vicki L. Shanker
Affiliation:
Beth Israel Medical Center, New York, NY, USA Email: [email protected]
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Letters to the Editor
Information
Canadian Journal of Neurological Sciences , Volume 39 , Issue 5 , September 2012 , pp. 680 - 681
Copyright
Copyright © The Canadian Journal of Neurological 2012

References

1.Orr, CF, Ahlskog, JE.Frequency, characteristics, and risk factors for amiodarone neurotoxicity. Arch Neurol. 2009;66:865–9.Google Scholar
2.Naranjo, CA, Busto, U, Sellers, EM, et al.A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239–45.CrossRefGoogle ScholarPubMed
3.Arnaud, A, Neau, JP, Rivasseau-Jonveaux, T, Marechaud, R, Gil, R.Neurological toxicity of amiodarone. 5 case reports. Rev Med Interne. 1992;13(6):419–22.Google Scholar
4.Rivest, J.Myoclonus. Can J Neurol Sci. 2003 Mar;30 Suppl 1:S53–8.Google Scholar
5.Aggarwal, A, Sharma, DD, Sharma, RC, Kumar, R.Probable psychosis associated with levetiracetam: a case report. J Neuropsychiatry Clin Neurosci. 2011;23(3):E19–20.Google Scholar